Navigation Links
Tiotropium surpasses Ipratropium

Tiotropium significantly improves lung function, dyspnoea and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to alternative therapy.// Previous studies have suggested that tiotropium may be the only treatment other than smoking cessation capable of reversing the symptoms of COPD. These latest findings are further evidence of the drug’s potential for treatment of the condition.

Dr Walter Vincken and colleagues from the Academic Hospital University of Brussels, Belgium, examined the effects of tiotropium compared to ipratropium in COPD patients over the period of one year. The group found that dyspnoea was reduced in the tiotropium patients by 31 per cent as compared to 18 per cent in the ipratropium group.

Quality of life measures increased by 52 per cent in the tiotropium group and 35 per cent in the ipratropium group. Moreover, frequency of exacerbations fell by 24 per cent more in the tiotropium group compared to the ipratropium group. This was associated with a reduction in hospitalisations of between 30 and 50 per cent and an increase in time to first exacerbation.

Researchers found that the beneficial effects of tiotropium on lung function persisted over a period of more than 24 hours. The researchers add that, once-daily treatment with tiotropium should be considered an effective first-line treatment for COPD
'"/>




Page: 1

Related medicine news :

1. A new study surpasses Gene Therapy Hurdle
2. Aspirin surpasses Modern Anti-clotting Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... Park Systems , a leader in Atomic ... SEMICONWest attendees and Park customers on July 11, 2017 from 12-2pm at the ... Chairman & CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... 2017 , ... Excel Medical, the leader in Next-Generation Medical ... Executive Vice President, Sales and Marketing. Finnegan is a widely known industry leader ... leadership. He has received industry recognition for innovations and new approaches to sales ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Harbour , ... token assets on the Ethereum blockchain, has released their technical specifications . , ... there has been little systematic approach for determining which offerings will garner the greatest ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... Association’s SUNucate efforts, Louisiana became the sixth state to pass legislation which ... Governor John Bel Edwards’ signature, Louisiana joins the states of Alabama, Arizona, Florida, ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... Ind. , June 13, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that the U.S. Food and Drug ... dated June 3, 2015 relating to its Zhejiang, ... "The successful clearance of the ... manufacturing facility is a measure of the progress ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
(Date:6/9/2017)... 9, 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders ... design, manufacture, sale and distribution of the AeroForm® Tissue ... of its commercial roll-out in the United ... than one hundred (100) medical institutions and health systems, ... a needle-free alternative for women who choose reconstructive surgery ...
Breaking Medicine Technology: